Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.0%

1 terminated out of 51 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

12%

6 trials in Phase 3/4

Results Transparency

9%

1 of 11 completed with results

Key Signals

1 with results92% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (19)
Early P 1 (1)
P 2 (3)
P 3 (4)
P 4 (2)

Trial Status

Unknown21
Completed11
Recruiting10
Not Yet Recruiting3
Active Not Recruiting3
Withdrawn2

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (51)

Showing 20 of 20 trials
NCT03960021Not ApplicableTerminated

Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin

NCT04696744CompletedPrimary

Prospective Study for the Prognostic and Predictive Role of Circulating Tumor Cells in Patients With Oropharyngeal Squamous Cell Carcinoma: CTCO (Circulating Tumor Cells in the Oropharynx)

NCT05360290Not ApplicableRecruiting

CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial

NCT05560776Not ApplicableActive Not Recruiting

Optimizing Endobronchial Ultrasound Sampling for Molecular Markers for NSCLC

NCT05346536Not ApplicableRecruiting

Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC)

NCT04544969RecruitingPrimary

Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC

NCT06755762RecruitingPrimary

Using a 3D Culture Model for Circulating Tumor Cells Combined With Molecular Bioassays in Patients With HNSCC Cancer

NCT04811846Not ApplicableActive Not Recruiting

CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood

NCT06557096Early Phase 1Not Yet Recruiting

CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC

NCT06469710Not Yet Recruiting

A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa Patients

NCT03776591Not ApplicableActive Not Recruiting

Open D3 Right Hemicolectomy Compared to Laparoscopic CME for Right Sided Colon Cancer

NCT06391892Phase 3Recruiting

Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery

NCT06317896Not Yet Recruiting

Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCS

NCT04800497Recruiting

The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC

NCT03700411Phase 4Completed

Influence of Opioid Analgesia on Circulating Tumor Cells in Open Colorectal Cancer Surgery

NCT03700541Phase 4Completed

Influence of Opioid Analgesia on Circulating Tumor Cells in Laparoscopic Colorectal Cancer Surgery

NCT06090214Not ApplicableUnknown

Liquid Biopsy for the Diagnosis of Intestinal-type Adenocarcinoma of the Ethmoid (BLADE)

NCT04648189Phase 2Withdrawn

Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC

NCT05964153Not ApplicableUnknown

Analysis of Circulating DNA in Blood Samples of Glioma-affected Patients

NCT05815082Phase 3Recruiting

ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer

Scroll to load more

Research Network

Activity Timeline